In India, the drug is sold under the brand name Obeda. In a news release, Health Canada says many generic medications are 45 to 90 per cent cheaper than brand-name versions
BioSpace Report Metseras regulatory filings later disclose that Novo Nordisk had submitted bids during this time that were rejected due to regulatory risks
The current clinical trials should give us more information: Theyre comparing which works better and which is safer, and results are expected in December 2026
Sajad Zalzala, receives questions like these from his patients all the time, which is why we turned to help answer some of the most common questions about Metformin and weight loss
They partnered with scientists in Zurich who were studying mice lacking the PAM gene
Future human studies will help us to better understand the big picture of this relationship, to hopefully provide mechanistic knowledge upon which new treatments could be created, such as microbiome-directed gene-therapies for the management of metabolic diseases
